Taiho Ventures

Activity from announced rounds

All recorded activity
Rounds participated in
5
Confirmed lead rounds
0
3 roles undisclosed
New companies
5
First participation on record · 0 follow-on
Funding in participating rounds
$603.1M
5 disclosed · full round size, not this investor’s share

By stage

Series B2
Seed1
Series C+1
Undisclosed1

By primary sector

Biotech5

By country

United States3
France1
United Kingdom1

Rounds

5 in all activity
Dren Bio

Dren Bio develops antibody therapies for cancer, autoimmune conditions and other serious diseases.

$350MPrivate financing
Participant
Signadori Bio

Develops in vivo engineered monocyte immunotherapy to treat solid tumours in preclinical stage

Role not disclosed
STORM Therapeutics

STORM Therapeutics develops cancer medicines that target enzymes responsible for chemical modifications to RNA.

$56MSeries C
Participant
EpiBiologics

Develops bispecific antibodies for targeted degradation of extracellular proteins.

$107MSeries B
Role not disclosed